Read More Pharma Industry News GSK’s Shingrix wins China approval for adults 18+ — Can this vaccine expansion reignite its global growth story? Find out how GSK’s Shingrix approval in China for adults aged 18+ could reshape its vaccine business and investor confidence. #GSK #Shingrix byPallavi MadhirajuOctober 15, 2025